Exciting News: Cardiol Therapeutics Wraps Up MAvERIC Phase II Study on Recurrent Pericarditis for AHA Scientific Sessions 2024
Cardiol Therapeutics Announces Completion of the Maveric Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart